Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy

Ocular Immunology and Inflammation

Volumn 14, Issue 2, 2006, Pages 87-90

  Paredes, I ^a,b   Ahmed, M ^a,b   Foster, C S ^a,b  

^a Massachusetts Eye Research and Surgery Institute   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Corticosteroids; Immunomodulatory therapy (IMT); Vogt Koyanagi Harada disease (VKH)

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DETERIORATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; MALE; MONOTHERAPY; PATIENT ASSESSMENT; SCHOOL CHILD; THERAPY DELAY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 33645768416     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940500536766     Document Type: Article

References (34)

1. Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:9-35.
2. Ohno S, Char DH, Kimura SJ, O'Connor GR. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1977;83(5):735-740.
3. Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980;90(1):69-75.
4. Chan CC. Relationship between sympathetic ophthalmia, phacoanaphylactic endophthalmitis and Vogt Koyanagi Harada disease. Ophthalmology. 1998;95(5):619-624.
5. Matsuda H, Sugiura S. Ultrastructural changes of the melanocyte in Vogt Koyanagi Harada syndrome and sympathetic ophthalmia. Jpn J Ophthalmol. 1971;15:69-80.
6. Norose K, Yano A, Aosai F, et al. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt Koyanagi Harada disease. Invest Ophthalmol Vis Sci. 1990;31:1210-1216.
7. Sakamoto T, Murata T, Inomata H. Class II major histocompatibility complex on melanocytes of Vogt Koyanagi Harada disease. Arch Ophthalmol. 1991;109:1270-1274.
8. Tagawa Y. Lymphocyte mediated cytotoxicity against melanocyte antigens in Vogt Koyanagi Harada syndrome. Jpn J Ophthalmol. 1978;22:36-41.
9. Read RW, Rao NA, Cunningham ET. Vogt Koyanaga Harada disease. Curr Opin Ophthalmol. 2000;11(6):437-442.
10. Shindo Y, Ohno S, Yamamoto T, et al. Complete association of the HLADRB1*04 and -DQB1*04 alleles with Vogt Koyanagi Harada's disease. Hum Immunol. 1994,39:169-176.
11. Weisz JM, Holland GN, Roer LN, et al. Association between Vogt Koyanagi Harada syndrome and HLA DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmol. 1995;102:1012-1015.
12. Kim MH, Seong MC, Kwak NH, et al. Association of HLA with Vogt Koyanagi Harada syndrome in Koreans. Am J Ophthalmol. 2000;129:173-177.
13. Pivetti-Pezzi P, Accorinti M, Colabelli-Gisoldi RA, et al. Vogt Koyanagi Harada disease and HLA type in Italian patients. Am J Ophthalmol. 1996;122:889-891.
14. Arellanes-Garcia L, Bautista N, Mora P, et al. HLA DR is strongly associated with Vogt Koyanagi Harada disease in Mexican Mestizo patients. Ocul Immunol Inflam. 1998;6:93-100.
15. Zhao M, Jiang Y, Abrahams IW. Association of HLA antigens with Vogt Koyanagi Harada syndrome in a Han Chinese population. Arch Ophthalmol. 1991;109:368-370.
16. Goldberg AC, Yamamoto JH, Chiarella JM, et al. HLADRB1*0405 is the predominant allele in Brazilian patients with Vogt Koyanagi Harada disease. Hum Immunol. 1998;59:183-188.
17. Riddington L, Hall AJ, Tait B, et al. Vogt Koyanagi Harada syndrome in patients of Vietnamese ancestry. Aust NZ J Ophthalmol. 1996;24:147-149.
18. Rubsamen PE, Gass JD. Vogt Koyanagi Harada Syndrome. Clinical course, therapy, and long-term visual outcome. Arch Opthalmol. 1991 May;109(5):682-687.
19. Rathiam SR, Vijayalakshmi P, Cunningham jr ET, et al. Vogt Koyanagi Harada syndrome in children. Ocul Immunol Inflam. 1998;6(3):155-161.
20. Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt Koyanagi Harada disease. Ophthalmologica. 1990;201(3):162-167.
21. Zhang M, Liu Q, Min H, Du H, Hu T. [Vogt Koyanagi Harada syndrome: glucocorticoid therapy and visual prognosis]. Zhonghua Yan Ke Za Zhi. 2002;38(4):200-203.
22. Biswas J, Rao NA. Management of intraocular inflammation. In: Ryan SJ, editor. Retina. Vol. 2. St. Louis: Mosby-Year Book, 1994; 1061-1069.
23. Rao NA, Blackman HJ, Franklin RM, et al. Intraocular inflammation and uveitis. In: Basic and clinical science course 1998-1999. San Francisco: American Academy of Ophthalmology, 1998; 76-79.
24. Hayasaka S, Okabe H, Takahashi J. Systemic corticosteroid treatment in Vogt Koyanagi Harada disease. Graefes Arch Clin Exp Ophthalmol. 1982;218(1):9-13.
25. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265-291.
26. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492-513.
27. Belfort Junior R, Nishi M, Hayashi S, et al. Vogt Koyanagi Harada's disease in Brazil. Jpn J Ophthalmol. 1988;32(3):344-347.
28. Nussenblat RB, Palestine AG, Chan CC. Cyclosporine therapy for uveitis: long term followup. J Ocul Pharmacol. 1985;1(4):369-382.
29. Vitale AT, Rodriguez A, Foster CS. Low dose cyclosporine A therapy in treating chronic, noninfectious uveitis. Ophthalmology. 1996;103(3):365-374.
30. Wakatsuki Y, Kogure M, Takahashi Y, Oguro Y. Combination therapy with cyclosporin A and steroid in severe case of Vogt Koyanagi Harada's disease. Jpn J Ophthalmol. 1988;32(3):358-360.
31. Wakefield D, McCluseky P, Reece G. Cyclosporin therapy in Vogt Koyanagi Harada disease. Aust NZ J Ophthalmol. 1990;18(2):137-142.
32. Ishioka M, Ohno S, Nakamura S, Isobe K, et al. FK506 treatment of noninfectious uveitis. Am J Ophthalmol. 1994;118(6):723-729.
33. Yang P, Wang H, Zhou H, Zhong H, et al. [Therapeutic regimen in Vogt Koyanagi Harada syndrome]. Zhonghua Yan Ke Za Zhi. 2002;38(4):196-199.
34. Limon S, Girard P, Bloch-Michel E, et al. [Current aspects of the Vogt Koyanagi Harada syndrome]. J Fr Ophtalmol. 1985;8(1):29-35.